Welcome to The QUEST Initiative
The QUality of life Evaluation STudy (QUEST Initiative), conducted by researchers at the University of Sydney, aims to be the world’s largest longitudinal clinical study investigating the quality of life and health economic impact of medicinal cannabis on patients with chronic disease.
Recruitment for the QUEST Initiative has now closed. The results from the study will be posted in 2023.
If you are interested in accessing medical cannabis you should first check your eligibility for medicinal cannabis by completing this survey: Am I Eligible
Patients accessing medicinal cannabis generally have a range of conditions and symptoms that impact their quality of life. This clinical study sets out to better understand and measure how these conditions and symptoms affect patients’ quality of life over time while they are accessing medicinal cannabis as a treatment option.
The QUEST Initiative concluded recruitment of eligible patients on the 31st of December 2021.
Why was the QUEST Initiative started?
The QUEST Initiative was established to help understand if a ‘new’ medical treatment could work and if it was good value for money. The study was designed to measure a person’s health and their response to medical cannabis as a treatment option. While length of life is easy to measure, quality of life is more subjective. Asking patients questions about different aspects of their health such as their mobility, functionality, pain or discomfort, and general well being was used to help measure progress. The QUEST Initiative measured these and other factors through online questionnaires. The de-identified results from this study will help future patients with certain diagnosed conditions to make better informed decisions about their treatment and understand the potential impact of medicinal cannabis on their overall quality of life.’
Please note: recruitment for The QUEST Initiative is now closed. If you are interested in upcoming medicinal cannabis studies, please complete form below.